Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Piper (Drug Discovery)

Piper (Drug Discovery)?uq=PEM9b6PF
2015 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$1M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of medical therapies intended to offer drugs focusing on the immune and inflammatory response. The company's therapies promote a microenvironment to inhibit tumour growth, slow sepsis, and calm autoimmune disease, enabling healthcare professionals to offer advanced and quick Medicare care to their patients.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Piper (Drug Discovery)’s full profile, request a free trial.

Piper (Drug Discovery) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 13-Oct-2016 $1M 00.00 Completed Generating Revenue
1. Seed Round 19-May-2016 00.00 00.00 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Piper (Drug Discovery) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Piper (Drug Discovery) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Altitude Life Science Ventures Venture Capital Minority 000 0000 000000 0
Pagliuca Harvard Life Lab Accelerator/Incubator Minority 000 0000 000000 0
Omega Fund Venture Capital Minority 000 0000 000000 0

Piper (Drug Discovery) Executive Team (1)

Name Title Board
Seat
Contact
Info
Russ Wilcox Co-Founder & Chief Executive Officer